Sawthropy治療市場：增長，趨勢，Covid-19影響和預測（2022-2027）

預計世界垂直腳治療的市場大小將在預測期間擴展9.5％的複合體。肌肉骨骼系統是浸泡腳的主要原因之一。

縫紉治療中的新趨勢預計將成為一個主要推進。例如，在2020年，Heliyon的提出的研究中，Pediankle Bot機器人被評估用於滴水腳治療。這有望增加對浸潤處理的需求。

在本報告中，我們調查了世界縫紉處理市場，並通過進入市場的公司的產品類型，使用，區域趨勢和型材提供市場概覽。

內容

第1章簡介

第2章測量方法

第3章執行摘要

第4章市場力學

• 市場概述
• 市場推廣因素
  • 一種隨著慢性病增加的負擔
  • 產品進步
• 市場抑制因子
  • 功能性電刺激裝置的高成本
• Porter的五個力分析

第5章市場細分

• 通過產品類型
  函數電刺激裝置
  • 支撐/衝刺
• 通過申請
  • 神經病變
  • 肌肉障礙
  • 腦和脊柱紊亂
• 按地區
  • 北美
  • 歐洲
  • 亞太地區
  • 中東，非洲
  • 南美洲

第6章衝突行為

• 公司簡介
  • Accelerated Care Plus Corporation
  • Allard
  • Axio Bionics
  • Bioness Inc.
  • Boston Orthotics &Prosthetics
  • Ossur
  • Ottobock
  • Saebo, Inc.
  • Thrive Orthopedics
  • Turbomed Orthotics

第7章 市場機會動向

The Foot Drop Treatment Market is expected to register a CAGR of 9.5% during the forecast period. Musculoskeletal is a disorder that leads to restricting your mobility and it is one of the major contributors worldwide for disability. Musculoskeletal is one of the major causes of foot drop. According to the Global Burden of Disease Study, in 2017, around 18.8 million people suffered from musculoskeletal conditions in the United Kingdom. Furthermore, emerging trends in the treatment of foot drop are expected to be a major driver. For instance, in 2020 a study was published by Heliyon, a pedi-anklebot robot was evaluated for foot drop treatment. Ankle motor performance was measured and great accuracy in terms of trajectories of the ankle was observed. Thus, it is expected to fuel the demand for foot drop treatment.

Key Market Trends

Functional Electrical Stimulator Segment is Expected to Show a Significant Growth Rate in the Foot Drop Treatment Market

* Functional Electrical Stimulator (FES) uses electrical pulses to stimulate the tissues that help in improving the motion, increasing blood circulation and prevents muscular atrophy. According to the study published by World Neurology, in 2019, a FES was evaluated for its effectiveness in regaining the functionality of foot. It was observed that FES was effective in the case of a normal walk among neurogenic drop foot patients.

* Furthermore, the growing burden of the brain and spinal disorders is expected to influence positively on the FES segment market. According to the Neurological Alliance, in 2018, the prevalence of cerebral palsy was approximately 25,273 in England.

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

North America expected to hold a major market share in the global foot drop treatment market due to the high prevalence of stroke and an increasing number of product approvals. Foot drop can arise due to a stroke. According to the Centre for Disease Control and Prevention, around 795,000 people experience stroke every year in the United States. Furthermore, in 2017, Bioness Inc. received a US FDA (Food Drug & Administration) for its L300 Go system. It involves tracking of user activity, detection of the 3D motion of gait movements and multi-channel stimulation. Hence, these factors are expected to boost the demand for foot drop treatment in this region.

Competitive Landscape

Companies are constantly showing their presence in the market by product launches, collaborations, mergers & acquisitions. For instance, in 2017, Saebo Inc. launched a new device "SaeboStep" into the market for the treatment of foot drop. Its unique design and light weight allow it to complement a variety of shoes. In terms of market share, few of the major players are currently dominating the market. Some of the companies which are currently dominating the market are Ottobock, Bioness Inc., Axio Bionics, Accelerated Care Plus Corporation, Saebo, Inc., Boston Orthotics & Prosthetics, Turbomed Orthotics, Ossur, Thrive Orthopedics and Allard.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 Study Assumptions
• 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Growing Burden of Chronic Diseases
  • 4.2.2 Advancements in Products
• 4.3 Market Restraints
  • 4.3.1 High Cost of Functional Electrical Stimulators
• 4.4 Porter's Five Force Analysis
  • 4.4.1 Threat of New Entrants
  • 4.4.2 Bargaining Power of Buyers/Consumers
  • 4.4.3 Bargaining Power of Suppliers
  • 4.4.4 Threat of Substitute Products
  • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION

• 5.1 By Product Type
  • 5.1.1 Functional Electrical Stimulator
  • 5.1.2 Braces/Splints
• 5.2 By Application
  • 5.2.1 Neuropathy
  • 5.2.2 Muscle Disorders
  • 5.2.3 Brain & Spinal Disorders
• 5.3 Geography
  • 5.3.1 North America
    • 5.3.1.1 United States
    • 5.3.1.2 Canada
    • 5.3.1.3 Mexico
  • 5.3.2 Europe
    • 5.3.2.1 Germany
    • 5.3.2.2 United Kingdom
    • 5.3.2.3 France
    • 5.3.2.4 Italy
    • 5.3.2.5 Spain
    • 5.3.2.6 Rest of Europe
  • 5.3.3 Asia-Pacific
    • 5.3.3.1 China
    • 5.3.3.2 Japan
    • 5.3.3.3 India
    • 5.3.3.4 Australia
    • 5.3.3.5 South Korea
    • 5.3.3.6 Rest of Asia-Pacific
  • 5.3.4 Middle-East and Africa
    • 5.3.4.1 GCC
    • 5.3.4.2 South Africa
    • 5.3.4.3 Rest of Middle-East and Africa
  • 5.3.5 South America
    • 5.3.5.1 Brazil
    • 5.3.5.2 Argentina
    • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

• 6.1 Company Profiles
  • 6.1.1 Accelerated Care Plus Corporation
  • 6.1.2 Allard
  • 6.1.3 Axio Bionics
  • 6.1.4 Bioness Inc.
  • 6.1.5 Boston Orthotics & Prosthetics
  • 6.1.6 Ossur
  • 6.1.7 Ottobock
  • 6.1.8 Saebo, Inc.
  • 6.1.9 Thrive Orthopedics
  • 6.1.10 Turbomed Orthotics

7 MARKET OPPORTUNITIES AND FUTURE TRENDS